Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Imiquimod 5 cream price?Matafarin warfarin brand croatia?Tolterodine tartrate 2mg price?Diclofenac brand name list?Cost of meropenem injection?
See the DrugPatentWatch profile for miralax
Miralax’s active ingredient is polyethylene glycol 3350 (PEG 3350). Miralax was developed by the pharmaceutical company Schering-Plough (now part of Merck), which later marketed it under the brand name Miralax in the United States.
There is no single widely cited “inventor” name publicly associated with Miralax as a branded product. Like most prescription/institutional drug developments, the formulation and manufacturing approach are typically credited through patents and company development teams rather than a lone individual.
If you’re looking for the legal/patent inventors, the most direct answer comes from the early patents for polyethylene glycol 3350 formulations and/or the specific Miralax formulation used for the marketed product. Those patent records list named inventors and assignees (companies).
Search the earliest patents covering: - polyethylene glycol 3350 as a laxative formulation - the specific Miralax brand formulation/manufacturing method - the use and dosing form tied to Miralax marketing If you tell me whether you mean (1) who developed the product for marketing (company) or (2) the named patent inventors, I can point you to the right type of record to match your intent. Sources: None provided in the prompt.
Other Questions About Miralax :